NYSTATIN TRIAMCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nystatin Triamcinolone Acetonide, and when can generic versions of Nystatin Triamcinolone Acetonide launch?
Nystatin Triamcinolone Acetonide is a drug marketed by Pharmaderm and is included in one NDA.
The generic ingredient in NYSTATIN TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystatin Triamcinolone Acetonide
A generic version of NYSTATIN TRIAMCINOLONE ACETONIDE was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NYSTATIN TRIAMCINOLONE ACETONIDE?
- What are the global sales for NYSTATIN TRIAMCINOLONE ACETONIDE?
- What is Average Wholesale Price for NYSTATIN TRIAMCINOLONE ACETONIDE?
Summary for NYSTATIN TRIAMCINOLONE ACETONIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NYSTATIN TRIAMCINOLONE ACETONIDE at DailyMed |
US Patents and Regulatory Information for NYSTATIN TRIAMCINOLONE ACETONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaderm | NYSTATIN TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 062596-001 | Oct 8, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
